To access this element change to forms mode OFF
Grant Award View - GA216991
Targeting immune resistance mechanisms to enhance anti-tumour immunity...
GA ID:
GA216991
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
17-Oct-2021
Publish Date:
7-Feb-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$108,317.80
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Targeting immune resistance mechanisms to enhance anti-tumour immunity in Non-Small Cell Lung Cancer
Purpose:
Lung cancer remains the leading cause of cancer related death globally. Treatments designed to unleash the immune system’s brakes (‘immunotherapy’) have resulted in significantly improved long-term survival in only a minority of patients. Tumour cells evolve to escape the immune system by silencing signals that allow their recognition by immune cells. We will identify means to reactivating these signals could enable immunotherapy to work in these otherwise resistant tumours.
GO ID:
GO Title:
2021 NHMRC Postgraduate Scholarship scheme
Internal Reference ID:
2021/GNT2013862
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA